Skip to main content
. 2021 Feb 11;12:952. doi: 10.1038/s41467-021-21257-6

Fig. 1. STARD diagram showing flow of participants through the study.

Fig. 1

Key. ET, endometrial thickness; ET <4 mm, histology not indicated; EC, endometrial cancer; PMB, postmenopausal bleeding. *Other cancers: ovarian (n = 1), fallopian tube (n = 2), cervical (n = 2). Cytology scoring: positive (vaginal and/or urine cytology positive); negative (both vaginal and urine cytology negative); inconclusive (both vaginal and urine cytology inadequate for assessment).